drugset / Trial / NCT03300115
Clinical Trial of the Efficacy and Safety of AC0010 in the Treatment of EGFR T790M Patients With Advanded NSCLC
Phase 2
Unknown
222 enrolled
Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Guangdong Provincial People's Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
The study is a single-arm, multi-center, open-label clinical trial. The study aims to expand the sample size based on the fixed dose recommended by the results of previous dose exploration studies in order to further evaluate the study drug's efficacy and safety.
Timeline
- Start
- 2017-05-18
- Primary completion
- 2019-06-17
- Completion
- 2020-12-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abivertinib | Small molecule | 300 mg | — |